The Impact of Covid-19 on the Pharmaceutical Industry Posted on 31. August 20201. September 2020 by c2p-editor
Andrew Badrot, CEO at C2 PHARMA speaking on Connecting industry across the globe, a Chemicals Knowledge Featured Story Posted on 27. August 20201. September 2020 by c2p-editor
Andrew Badrot, CEO of C2 PHARMA, speaking on how the pharma industry has responded to the COVID-19 pandemic, a Pharma’s Almanac Q2 issue Posted on 1. July 20207. July 2020 by c2p-editor
Lessons from a modern-day pandemic: redesigning the pharmaceutical supply chain, a Manufacturing Chemist featured story Posted on 15. May 20207. July 2020 by c2p-editor
COVID-19/Coronavirus is reshaping the pharmaceutical supply chain Posted on 27. April 20207. July 2020 by c2p-editor
C2 PHARMA Opens Government and Research Access to Safety Stock of DIGOXIN API for Use in Potential COVID-19/Coronavirus Combination Treatment Posted on 26. March 20207. July 2020 by c2p-editor
Andrew Badrot, CEO of C2 PHARMA, weighing in on the future trends of mergers and acquisitions in the life sciences industry Posted on 19. March 20207. July 2020 by c2p-editor
Fairness in the pharma supply chain key to success in today’s business climate Posted on 9. January 20207. July 2020 by c2p-editor
Andrew Badrot, CEO of C2 PHARMA, speaking on developing technologies that will have the greatest impact on the biopharma industry in 2020 and beyond, a Pharma’s Almanac Q4 issue Posted on 6. December 20197. July 2020 by c2p-editor